Renata Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Renata Limited with three other
pharmaceutical manufacturers in Asia:
sales of 21.52 billion Indian Rupees [US$294.56 million]
of which 100%
Beximco Pharmaceuticals Limited
(25.61 billion Bangladeshi Taka [US$301.96 million]
Dishman Carbogen Amcis Ltd
based in INDIA
(20.44 billion Indian Rupees [US$279.77 million]
of which 74%
Renata Limited reported sales of 24.67 billion Bangladeshi Taka (US$290.92 million)
June of 2020.
increase of 8.2%
versus 2019, when the company's sales were 22.81 billion Bangladeshi Taka.
Sales at Renata Limited have increased during each of the previous five years
(and since 2015, sales have increased a total of 84%).